Public Health Update–8 May 2026: Pembrolizumab CRC durability, Argentina hantavirus outbreak & More

Rare Diseases Update – 7 May 2026: Intellia BLA, Tavneos Withdrawal and More

Cardiovascular Update – 7 May 2026: Aficamten Hits Endpoints, FDA Relay Pro Warning and More

Immunology Update – 6 May 2026: Rhapsido, Saphnelo Pen and More

Endocrinology Update – 5 May 2026: Tzield Pediatric Expansion, Semaglutide Teens Data and More

Hematology Update – 4 May 2026: Blenrep China Approval, Jakafi XR Approval and More

Respiratory Research Update – 30 Apr 2026: ENFLONSIA EU Approval, Breztri Asthma Approval and More

Vaccines Research Update – 30 Apr 2026: EU approval of flu-COVID vaccine, H5 Phase 3 advance & More

Gene and Cell Therapy Update – 30 Apr 2026: Otarmeni Approval, Kelonia Deal and More

Neuroscience Update – 29 Apr 2026: CAPLYTA sNDA, Itvisma CHMP and More

Women’s Health Update – 29 Apr 2026: Sun Pharma-Organon, Phase 3 Afuresertib and More

Obesity Update – 28 Apr 2026: Lilly Oral GLP-1 Launches, FDA Foundayo Safety and More

ARTIFICIAL INTELLIGENCE and DIGITAL HEALTH Update – 28 April 2026: GPT-Rosalind Launch and More

Oncology Update – 27 Apr 2026: Ifinatamab Priority Review, Ojemda EU Approval and More

Public Health Update – 24 April 2026: Gene Therapy Hearing Breakthrough, AI Chatbot Safety and More

Rare Diseases Update – 23 Apr 2026: Filspari approved in FSGS, ENSPRYNG MOGAD data and more

Cardiovascular Update – 23 Apr 2026: Trilogy launch in US, UK approval for Bayer's Kerendia and More

Immunology Update – 22 Apr 2026: Dupixent EU CSU, Saphnelo Canada SLE and More

Endocrinology Update – 21 Apr 2026: DENOZA Approval, Biocon Launch and More

Hematology Update – 20 Apr 2026: Jaypirca Phase 3 Success, OPN-6602 Fast Track and More

Vaccines Research Update – 17 Apr 2026: Marburg Trial, Nuvaxovid Canada and More

Respiratory Update – 17 Apr 2026: Generic Nintedanib Approval, Exdensur China Nod and More

Gene and Cell Therapy Update – 16 Apr 2026: UX111 BLA Accepted, WU-CART-007 Breakthrough and More

Women’s Health Update – 15 Apr 2026: At-home HPV screening clearance, CRB-701 FDA alignment

Neuroscience Update – 15 Apr 2026: Spinraza Higher-Dose FDA Approval and More

Obesity Update – 14 Apr 2026: FDA Clears Foundayo, Wegovy HD Launch and More

Oncology Update – 14 Apr 2026: KEYTRUDA EU Approval, Bezuclastinib NDA and More

Public Health Update – 10 Apr 2026: Phthalates Linked to Early Birth, Multi-Cancer Blood Test & More

Rare Diseases Update – 9 Apr 2026: AVLAYAH FDA Approval, VYKAT XR Deal and More

Cardiovascular Update – 9 Apr 2026: Repatha Benefit, FDA Breakthrough AI and More

Immunology Update – 8 April 2026: Rezurock EU Approval, Fabhalta Phase 3 and More

Endocrinology Update – 7 Apr 2026: FDA Approves Awiqli, GZR4 Phase 3 Success and More

ARTIFICIAL INTELLIGENCE and DIGITAL HEALTH Update – 6 April 2026: Lilly Insilico deal and More

Hematology Update – 6 Apr 2026: Sarclisa SC EU Opinion, DARZALEX Self-Admin and More

Vaccines Update – 3 April 2026: VAX-31 Phase 3, Qdenga India Nod and More

Respiratory Research Update – 3 April 2026: ARIKAYCE Phase 3b Success, Tozorakimab Phase 3 and More

Gene and Cell Therapy Update – 2 April 2026: KRESLADI FDA Approval, BBM-H901 Macao Approval

Women’s Health Update – 1 April 2026: FYLREVY EU approval, atirmociclib Phase 2 and More

Neuroscience Update – 1 April 2026: AVLAYAH FDA Approval, Relutrigine Priority Review and More

Obesity Update – 31 Mar 2026: Imcivree FDA Approval, Semaglutide Generics and More

Oncology Update – 30 Mar 2026: Imfinzi EU Approval, Zepzelca CHMP Backing and More

Public Health Update – 27 Mar 2026: CAR-T in MS, Cholesterol Guidelines and More

Rare Diseases Update – 26 Mar 2026: Dupixent Japan Approval, OTC Gene Therapy Phase 3 and More

Cardiovascular Update – 26 Mar 2026: JenaValve FDA Approval, Asundexian Data and More

Immunology Update – 25 Mar 2026: Lynavoy PBC Approval, ICOTYDE in Psoriasis and More

Endocrinology Update – 24 Mar 2026: Retatrutide Phase 3, Generic Semaglutide and More

ARTIFICIAL INTELLIGENCE and DIGITAL HEALTH Update – 23 Mar 2026: EMA FDA AI Principles and More

Hematology Update – 23 Mar 2026: TECVAYLI EMA Filing, Nivolumab Approval and more

Vaccines Research Update – 20 Mar 2026: Arexvy FDA Expansion, ETVAX Data and More

Respiratory Research Update – 20 Mar 2026: MOLBREEVI FDA Progress, Tyvaso Phase 3 Data and More

Gene and Cell Therapy Update – 19 Mar 2026: ST-920 BLA Progress, Deramiocel PDUFA and More

Women’s Health Update – 18 Mar 2026: Enhertu Priority Review, Roche Phase III and More

Neuroscience Update – 18 Mar 2026: Phase 3 HARMONIA in DM1, Roche ApoE4 CE Mark and More

Obesity Update – 17 Mar 2026: China Approves Ecnoglutide, ASC30 Phase II Data and More

Oncology Update – 16 Mar 2026: ENHERTU Priority Review and Zynyz EU Approval and More

Public Health Update – 13 Mar 2026: Gene Therapy Breakthrough, Antibiotic Pipeline Concerns and More

Rare Diseases Update – 12 Mar 2026: ST-920 BLA Progress, JUXTAPID Pediatric Approval and More

Cardiovascular Update – 12 Mar 2026: Abbott CardioMEMS HERO FDA Clearance, Relief Implant and More

ARTIFICIAL INTELLIGENCE and DIGITAL HEALTH Update – 11 Mar 2026: ChatGPT Health safety study & more

Immunology Update – 11 March 2026: Sotyktu PsA Approval, Dupixent AFRS Approval and More